Determining the extent to which clinically effective treatment, ustekinumab or etanercept, reverses the molecular disease profile of psoriatic skin: comparisons of lesional, non-lesional and normal skin

被引：0
|
作者：
Krueger, J. [1 ]
Li, K. [2 ]
Baribaud, F. [2 ]
Suarez-Farinas, M. [1 ]
Brodmerkel, C. [2 ]
机构：
[1] Rockefeller Univ, New York, NY 10021 USA
[2] Centocor Inc, Res & Dev, Malvern, PA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2010年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
298
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 11 条
  • [1] Determining the extent to which clinically effective treatment, ustekinumab or etanercept, reverses the molecular disease profile of psoriatic skin: comparisons of lesional, non-lesional and normal skin
    Brodmerkel, Carrie
    Li, Katherine
    Baribaud, Frederic
    Suarez-Farinas, Mayte
    Krueger, James
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [2] Determining the extent to which clinically effective treatment, ustekinumab or etanercept, reverses the molecular disease profile of psoriatic skin: Comparisons of lesional, non-lesional and normal skin
    Krueger, James
    Li, Katherine
    Baribaud, Frederic
    Suarez-Farinas, Mayte
    Brodmerkel, Carrie
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S59 - S59
  • [3] Determining the extent to which clinically effective treatment, ustekinumab or etanercept, reverses the molecular disease profile of psoriatic skin: Comparisons of lesional, nonlesional, and normal skin
    Krueger, J.
    Brodmerkel, C.
    Li, K.
    Suarez-Farinas, M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB7 - AB7
  • [4] Comparisons of gene expression in normal, lesional, and non-lesional psoriatic skin using DNA microarray techniques
    Xie, Shaoqiong
    Chen, Zhongjian
    Wang, Qingliang
    Song, Xun
    Zhang, Linglin
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (10) : 1213 - 1220
  • [5] Fluorescent fibre-optic confocal imaging of lesional and non-lesional psoriatic skin compared with normal skin in vivo
    Suihko, Christian
    Serup, Jorgen
    SKIN RESEARCH AND TECHNOLOGY, 2012, 18 (04) : 397 - 404
  • [6] DIFFERENTIAL BEHAVIOR OF 3 SOLUBLE MEMBRANE MOLECULES IN SERA AND SUCTION BLISTER FLUIDS FROM LESIONAL AND NON-LESIONAL SKIN OF PSORIATIC PATIENTS - COMPARISON WITH SKIN OF NORMAL DONORS
    FAZIO, M
    BONIFATI, C
    ALEMANNO, L
    CARDUCCI, M
    MUSSI, A
    SACERDOTI, G
    CORDIALIFEI, P
    AMEGLIO, F
    EUROPEAN JOURNAL OF DERMATOLOGY, 1994, 4 (06) : 476 - 479
  • [7] Prevalence of human papilloma virus type 5 DNA in lesional and non-lesional skin scales of Italian plaque-type psoriatic patients: association with disease severity
    Prignano, G
    Ferraro, C
    Mussi, A
    Stivali, F
    Trento, E
    Bordignon, V
    Crescimbeni, E
    Salvati, G
    Degener, AM
    Ameglio, F
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (01) : 47 - 51
  • [8] Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin
    Quist, S. R.
    Quist, J.
    Birkenmaier, J.
    Stauch, T.
    Gollnick, H. P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (09) : 1537 - 1543
  • [9] The molecular profile of psoriatic skin in responders to ustekinumab or etanercept after 12 weeks of treatment: Results from the ACCEPT trial
    Krueger, James
    Brodmerkel, Carrie
    Li, Katherine
    Suarez-Farinas, Mayte
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB13 - AB13
  • [10] The Molecular Profile of Psoriatic Skin in Responders to Ustekinumab or Etanercept Following Twelve Weeks of Treatment: Results from the ACCEPT Trial
    Krueger, J.
    Li, K.
    Baribaud, F.
    Suarez-Farinas, M.
    Brodmerkel, C.
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (02) : 179 - 180
12